Yangtze River Industry Fund, founded in 2016, functions as a private equity investment firm based in Wuhan, Hubei, China. The firm is dedicated to engaging in funding activities across various sectors, aiming to support the growth and development of emerging companies. Its operational status is active, and it maintains a private liquidity status, characteristic of its investment model within the venture capital landscape. The fund has demonstrated its investment activity through its participation in significant funding rounds. For instance, Yangtze River Industry Fund contributed to the financial backing of ArchForce Financial Technology, a company operating within the technology sector. This involvement highlights the firm's role in providing crucial capital to developing enterprises that align with its investment criteria. Furthermore, Yangtze River Industry Fund has also extended its support to the biotechnology sector, evidenced by its investment in Neurophth Therapeutics. Such strategic investments underscore the firm's commitment to fostering innovation and advancing progress within specialized industries, thereby expanding its portfolio across diverse high-growth areas. While the firm's official website, zjevt.com, is primarily associated with EVTECH, Yangtze River Industry Fund is explicitly identified as a partner alongside other well-known enterprises and governments on EVTECH's "About Us" page. This suggests a collaborative relationship or a strategic interest in the technology company, potentially indicating a broader engagement beyond direct equity investments in certain cases. The firm continues to operate as a dedicated investment entity within the Chinese market, leveraging its strategic partnerships and capital deployment to influence the regional venture ecosystem.
